IDH1 c.415T>G ;(p.Y139D)

Variant ID: 2-209110148-A-C

NM_005896.2(IDH1):c.415T>G;(p.Y139D)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: IDH1: Y139D
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: IDH1: Y139D
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients.

Scientific Reports
Acquaviva, Giorgia G; Visani, Michela M; de Biase, Dario D; Marucci, Gianluca G; Franceschi, Enrico E; Tosoni, Alicia A; Brandes, Alba A AA; Rhoden, Kerry J KJ; Pession, Annalisa A; Tallini, Giovanni G
Publication Date: 2018-03-13

Variant appearance in text: IDH1: Y139D
PubMed Link: 29535392
Variant Present in the following documents:
  • Main text
View BVdb publication page



High-Throughput Assessment of Structural Continuity in Biologics.

Analytical Chemistry
Musetti, Caterina C; Bean, Mark F MF; Quinque, Geoffrey T GT; Kwiatkowski, Christopher C; Szewczuk, Lawrence M LM; Baldoni, John J; Zajac, Matthew A MA
Publication Date: 2018-02-20

Variant appearance in text: IDH1: Y139D
PubMed Link: 29369625
Variant Present in the following documents:
  • Main text
  • ac8b00180_si_001.pdf
  • ac8b00180.pdf
View BVdb publication page



IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.

Neuro-Oncology
Zhang, Chunzhi C; Moore, Lynette M LM; Li, Xia X; Yung, W K Alfred WK; Zhang, Wei W
Publication Date: 2013-09

Variant appearance in text: IDH1: Y139D
PubMed Link: 23877318
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.

Oncogene
Ward, P S PS; Cross, J R JR; Lu, C C; Weigert, O O; Abel-Wahab, O O; Levine, R L RL; Weinstock, D M DM; Sharp, K A KA; Thompson, C B CB
Publication Date: 2012-05-10

Variant appearance in text: IDH1: Y139D
PubMed Link: 21996744
Variant Present in the following documents:
  • Main text
View BVdb publication page